Jacob Van Naarden - EVP & Pres., Lilly Oncology at ELI LILLY & Co

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Pres., Lilly Oncology
Issuer Symbol
LLY on NYSE
All Insider Reports
All Insider Reports

Jacob Van Naarden - trading volume in the past year for ELI LILLY & Co

Holdings reported by Jacob Van Naarden for ELI LILLY & Co

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 20,562 $13,311,006 $647.36 13 Aug 2025 Direct
Restricted Stock Unit 4,108 $3,569,359 $868.88 10 Feb 2025 Direct Common Stock
Common Stock 4,342 $3,187,766 $734.17 13 Aug 2025 Van Naarden Family Trust
Common Stock 4,302 $3,158,399 $734.17 13 Aug 2025 By spouse

Transactions reported by Jacob Van Naarden for ELI LILLY & Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.